In
recent years, the demand for detection and diagnostic methods
has consistently risen due to the aging of the population and the
increase in the number of patients with chronic diseases. Label-free
biomedical detection techniques have emerged as indispensable instruments
for diagnosing a variety of diseases. The development of label-free
and highly sensitive near-infrared (NIR) biomedical detection technology
has attracted considerable attention. As a label-free, swift, and
cost-effective analytical technique, it has demonstrated immense potential
for a wide range of applications. We successfully assembled FAPbI3 near-infrared perovskite quantum dots (NIPQDs) into SiO2 shells using a rapid room-temperature atmospheric synthesis
method, obtaining monodisperse FAPbI3@SiO2 nanocomposites
(NCs) with a high photoluminescence quantum yield (PLQY) of 72%. Additionally,
the incorporation of hydrophobic multi-branched trioctylphosphine
oxide effectively passivated the surface defects of FAPbI3 NIPQDs and suppressed the hydrolysis rate of tetraethoxysilane,
enabling the formation of a highly stable and high PLQY nanoscale-particle
level within the FAPbI3@SiO2 core–shell
structure. Notably, we successfully incorporated FAPbI3@SiO2 core–shell NCs onto InGaN blue chip as NIR
excitation light sources for surface plasmon resonance sensing platforms,
providing a novel platform for bioanalytical detection. With a detection
sensitivity of 6302.5 nm/RIU, the system demonstrated high sensitivity,
stability, and dependability. This achievement expands the biomedical
research field’s capacity for diagnosis, monitoring, and treatment.